Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Beckman Coulter Unveils Advanced Cydem VT Automated Screening System
Research & Development Beckman Coulter Unveils Advanced Cydem VT Automated Screening System

Beckman Coulter Life Sciences, a subsidiary of Danaher Corporation, has announced the launch of the Cydem VT Automated Clone Screening System, an innovative platform designed to transform the world of drug discovery through advanced laboratory automation and innovation. This groundbreaking

Innovative Technologies Revolutionize Platelet Function Assessments
Research & Development Innovative Technologies Revolutionize Platelet Function Assessments

Platelets play an essential role in human physiology, particularly during the clotting process in response to injury. Despite their importance, the comprehension and measurement of platelet functionality have consistently posed challenges for scientists and clinicians. This issue has become even

Emerging Health Technologies Transforming Modern Medical Practices
Tech & Innovation Emerging Health Technologies Transforming Modern Medical Practices

In today's rapidly evolving technological landscape, the medical field is experiencing an unprecedented wave of innovation with advancements that hold the potential to transform medical practices significantly. Among the leading areas of development are nanotechnology, holographic

Can a Nasal Spray Halt Alzheimer's Progression by Targeting Enzymes?
Research & Development Can a Nasal Spray Halt Alzheimer's Progression by Targeting Enzymes?

A promising new approach in battling Alzheimer's disease has emerged, involving an innovative nasal spray drug that targets a specific brain enzyme. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that inhibiting the enzyme

Can MT1988 Revolutionize Treatment for Cognitive Impairment in Schizophrenia?
Research & Development Can MT1988 Revolutionize Treatment for Cognitive Impairment in Schizophrenia?

Schizophrenia is a severe mental health disorder that ranks as one of the leading causes of disability worldwide, significantly impacting memory, attention, and executive function. Despite the profound challenges it presents, there are currently no approved treatments for cognitive impairment

How Are New Technologies Revolutionizing Cancer Research and Treatment?
Research & Development How Are New Technologies Revolutionizing Cancer Research and Treatment?

Recent scientific advancements in cancer research are unveiling the complex behaviors and interactions within tumors through innovative technologies such as 3D tumor mapping and single-cell analysis. These methods allow researchers to delve deeper into the intricacies of tumor development and

Can Effective Interventions Reduce Tooth Decay in Young Children?
Research & Development Can Effective Interventions Reduce Tooth Decay in Young Children?

Tooth decay among young children is a significant public health concern in England, affecting up to 50% of 5-year-olds and often leading to severe pain and dental extractions under general anesthetic. Researchers at the University of Manchester, in collaboration with Manchester's Oral Health

Revolutionizing Beauty and Health: NihonChojyu Clinic Expands to Thailand
Research & Development Revolutionizing Beauty and Health: NihonChojyu Clinic Expands to Thailand

The launch of an advanced cell restoration treatment in Thailand marks a significant milestone in the Thai-Japan partnership. NihonChojyu Clinic, established by Dr. Masatoshi Egoshi, is at the forefront of this healthcare innovation, emphasizing the restoration of health and beauty from the

Is Cetuximab More Effective Than Durvalumab for Head and Neck Cancer?
Research & Development Is Cetuximab More Effective Than Durvalumab for Head and Neck Cancer?

Head and neck cancers rank as the seventh most common type of cancer globally, significantly impacting smokers, drinkers, and individuals with HPV infections. Cisplatin, a standard chemotherapy drug, coupled with radiation therapy, remains the gold standard for treating these cancers. However, over

How Does TRISCO Revolutionize 3D RNA Analysis in Intact Mouse Brains?
Tech & Innovation How Does TRISCO Revolutionize 3D RNA Analysis in Intact Mouse Brains?

In a revolutionary breakthrough, researchers at Karolinska Institutet and Karolinska University Hospital have developed an innovative microscopy technique called TRISCO, which allows for intricate three-dimensional (3D) RNA analysis at cellular resolution in whole, intact mouse brains. This

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later